Does CEFTAZIDIME Cause Injection site extravasation? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Injection site extravasation have been filed in association with CEFTAZIDIME (TAZICEF). This represents 1.0% of all adverse event reports for CEFTAZIDIME.
33
Reports of Injection site extravasation with CEFTAZIDIME
1.0%
of all CEFTAZIDIME reports
0
Deaths
33
Hospitalizations
How Dangerous Is Injection site extravasation From CEFTAZIDIME?
Of the 33 reports, 33 (100.0%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFTAZIDIME. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does CEFTAZIDIME Cause?
Drug ineffective (518)
Off label use (266)
Condition aggravated (228)
Septic shock (200)
Acute kidney injury (191)
Pyrexia (176)
Endophthalmitis (128)
Multiple organ dysfunction syndrome (124)
Neutropenia (123)
Drug reaction with eosinophilia and systemic symptoms (121)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which CEFTAZIDIME Alternatives Have Lower Injection site extravasation Risk?
CEFTAZIDIME vs CEFTIBUTEN
CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM
CEFTAZIDIME vs CEFTRIAXONE
CEFTAZIDIME vs CEFTRIAXONE\CEFTRIAXONE
CEFTAZIDIME vs CEFUROXIME